You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

abi-009

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma Trial in Fullerton, Newport Beach, Santa Monica (ABI-009,

Active, not recruiting
  • High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
  • ABI-009
  • +5 more
  • Fullerton, California
  • +2 more
Jun 13, 2022

PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

Approved for marketing
  • PEComa, Malignant
  • +3 more
  • ABI-009
  • (no location specified)
Mar 2, 2022

PEComa Trial in United States (ABI-009)

Completed
  • PEComa
  • ABI-009
  • Palo Alto, California
  • +8 more
Apr 29, 2022

Non-muscle Invasive Bladder Cancer (NMIBC) Trial in New York, Nashville (ABI-009, Gemcitabine)

Completed
Has Results
  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • New York, New York
  • +1 more
May 12, 2021

Neuroendocrine Tumors Trial in New Orleans (ABI-009)

Terminated
Has Results
  • Neuroendocrine Tumors
  • ABI-009
  • New Orleans, Louisiana
    Ochsner Clinic Foundation
May 17, 2021

Epilepsy Intractable Trial in Seattle (ABI-009)

Unknown status
  • Epilepsy Intractable
  • ABI-009
  • Seattle, Washington
    Seattle Children's Hospital
Oct 19, 2020

Solid Tumors Trial in Santa Monica, Houston (ABI-009)

Completed
  • Solid Tumors
  • ABI-009
  • Santa Monica, California
  • +1 more
Oct 16, 2019

Multiple Myeloma Trial in Boston (ABI-009, Pomalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • ABI-009
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 12, 2019